Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion (Q42815079)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 1997

Language	Label	Description	Also known as
English	Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion	scientific article published on June 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

M Peiper

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

M Nagoshi

2

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

D Patel

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

J A Fletcher

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

P S Goegebuure

5

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

T J Eberlein

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

1 June 1997

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

993-999

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

describes a project that uses

0 references

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Vaccine therapy for cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970611%2971%3A6%3C993%3A%3AAID-IJC15%3E3.0.CO%3B2-7

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19970611)71:6<993::AID-IJC15>3.0.CO;2-7

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42815079&oldid=1971038534"